Where can I verify the source and access all details for “Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility”?

This Taiyo project page references The Economic Times along with the original URL (https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/glenmarks-monroe-facility-classified-as-voluntary-action-indicated-by-usfda/amp_articleshow/125606383.cms). Taiyo standardizes official data into a consistent, searchable project profile.

Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility

Q: What is the latest status of the project “Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility”?

The status recorded for “Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility” is voluntary action indicated.

Sector: Commercial • Location: Monroe, North Carolina, United States

Source: The Economic Times

Project

Voluntary Action Indicated

Glenmark Pharmaceuticals' formulations manufacturing facility in Monroe, North Carolina, was inspected by the US health regulator from June 9 to June 17, 2025. The facility has been classified as Voluntary Action Indicated by the USFDA, allowing the company to restart commercial manufacturing at the site.

Status: Prospective
Sector: Commercial, Manufacturing (Industrial)
Location: Monroe, North Carolina, United States of America
Updated: 22 Jul 2026
Source: The Economic Times

ConstructChat

Ask ConstructChat about Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

3 Q

The project “Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility” is an infrastructure initiative in the Commercial sector, located in Monroe, North Carolina, United States. Taiyo aggregates data on it from The Economic Times.

Participants

Not available for this record.

Status

Original status	voluntary action indicated
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Glenmark Pharmaceuticals' formulations manufacturing facility in Monroe, North Carolina, was inspected by the US health regulator from June 9 to June 17, 2025. The facility has been classified as Voluntary Action Indicated by the USFDA, allowing the company to restart commercial manufacturing at the site.
Original sector	Healthcare/Biotech

Location

Country	United States of America (USA)
State	North Carolina
City	Monroe

Source

Source	The Economic Times
URL

More Details

Record type	Project
Sector	Commercial, Manufacturing (Industrial)
Article published date	2025-11-29

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility

Ask ConstructChat about Glenmark Pharmaceuticals Monroe Formulations Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Commercial projects in United States